{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:06:42Z","timestamp":1776409602371,"version":"3.51.2"},"reference-count":203,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Antibiot."],"abstract":"<jats:p>The worldwide increasing frequency and severity of multidrug-resistant gastrointestinal (MDR-GI) infections not only raises awareness of the debilities of conventional antibiotic treatments but also highlights the demand for alternative interventions. One of these alternatives is probiotics, harmless bacteria that compete with pathogenic species, which have been considered beneficial due to their therapeutic potential since they strengthen the mucosal barrier and modulate the host immune response. Other natural compounds (e.g., polyphenols, flavonoids, and essential oils) present diverse antimicrobial mechanisms, which are promising alternatives to mitigate resistant pathogens. Finally, bacteriophages, viruses that target specific bacteria, constitute a precise approach in which MDR bacteria are lysed or disrupted by the biofilms formed during colonization without compromising the normal gut microbiome. Therefore, the present manuscript provides an integrated perspective on alternative non-antibiotic therapies to manage MDR-GI infections; for this purpose, it covers aspects such as their action mechanisms, current clinical applications, and the challenges that limit their broader application in clinical practice. The potential of combining these approaches or personalizing infection treatments adjusted to patients\u2019 microbiome profiles is also discussed, aiming to enhance efficacy and reduce resistance risks. Finally, the importance of continued research and development to optimize these alternatives is also debated, addressing aspects such as the need to surpass regulatory barriers and conducting large-scale clinical trials to establish the safety and efficacy of these non-antibiotic alternatives. This overview of the current knowledge contributes to the ongoing efforts to develop sustainable strategies to combat MDR-GI infections and reduce the global burden of antibiotic resistance.<\/jats:p>","DOI":"10.3389\/frabi.2025.1554061","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T05:26:54Z","timestamp":1746509214000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Non-antibiotic therapies for multidrug-resistant gastrointestinal infections: an overview of the use of probiotics, natural compounds, and bacteriophages"],"prefix":"10.3389","volume":"4","author":[{"given":"Manuela","family":"Oliveira","sequence":"first","affiliation":[]},{"given":"\u00c1urea","family":"Madureira-Carvalho","sequence":"additional","affiliation":[]},{"given":"Ricardo Jorge","family":"Dinis-Oliveira","sequence":"additional","affiliation":[]},{"given":"Diana","family":"Dias da Silva","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8100405","article-title":"Tackling antibiotic resistance with compounds of natural origin: A comprehensive review","volume":"8","author":"\u00c1lvarez-Mart\u00ednez","year":"2020","journal-title":"Biomedicines"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s13346-023-01318-y","article-title":"Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges","volume":"14","author":"Andreani","year":"2024","journal-title":"Drug Delivery Trans. Res."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12040635","article-title":"About functional foods: The probiotics and prebiotics state of art","volume":"12","author":"Ballini","year":"2023","journal-title":"Antibiotics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02981","article-title":"The regulation of host intestinal microbiota by polyphenols in the development and prevention of chronic kidney disease","volume":"10","author":"Bao","year":"2020","journal-title":"Front. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41467-024-47192-w","article-title":"Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model","volume":"15","author":"Berkson","year":"2024","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/nu14163323","article-title":"Factors determining effective probiotic activity: evaluation of survival and antibacterial activity of selected probiotic products using an \u201cin vitro\u201d study","volume":"14","author":"Bernatek","year":"2022","journal-title":"Nutrients"},{"key":"B7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1080\/1040841X.2022.2026423","article-title":"The microbiome and precision oncology: An emerging paradigm in anticancer therapy","volume":"48","author":"Bhat","year":"2022","journal-title":"Crit. Rev. Microbiol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.613077","article-title":"Antibacterial properties of organosulfur compounds of garlic (Allium sativum)","volume":"12","author":"Bhatwalkar","year":"2021","journal-title":"Front. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2174\/1389201022666211104125455","article-title":"Recent advances in clinical utility of probiotics in gastrointestinal tract disorders","volume":"22","author":"Biswasroy","year":"2021","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae017","article-title":"Improving phage therapy by evasion of phage resistance mechanisms","volume":"6","author":"Bleriot","year":"2024","journal-title":"JAC-Antimicrobial Resistance"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9100998","article-title":"Solid lipid nanoparticles as carriers of natural phenolic compounds","volume":"9","author":"Borges","year":"2020","journal-title":"Antioxidants"},{"key":"B12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/eva.13518","article-title":"Comparison of bacterial suppression by phage cocktails, dual-receptor generalists, and coevolutionarily trained phages","volume":"16","author":"Borin","year":"2023","journal-title":"Evolutionary Appl."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27051484","article-title":"Mechanisms, anti-quorum-sensing actions, and clinical trials of medicinal plant bioactive compounds against bacteria: A comprehensive review","volume":"27","author":"Bouyahya","year":"2022","journal-title":"Molecules"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13060522","article-title":"Does phage therapy need a pan-phage","volume":"13","author":"Bozidis","year":"2024","journal-title":"Pathogens"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01161","article-title":"Good manufacturing practice (GMP) compliance for phage therapy medicinal products","volume":"11","author":"Bretaudeau","year":"2020","journal-title":"Front. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1053\/j.gastro.2020.09.062","article-title":"Probiotics and the microbiome: How can we help patients make sense of probiotics","volume":"160","author":"Britton","year":"2021","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1057\/s41599-020-0471-8","article-title":"Phage therapy as a potential solution in the fight against AMR: Obstacles and possible futures","volume":"6","author":"Brives","year":"2020","journal-title":"Palgrave Commun."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10060672","article-title":"Advances in bacteriophage therapy against relevant multidrug-resistant pathogens","volume":"10","author":"Broncano-Lavado","year":"2021","journal-title":"Antibiotics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01878-z","article-title":"Drug-resistant enteric fever worldwide to 2018: a systematic review and meta-analysis","volume":"18","author":"Browne","year":"2020","journal-title":"BMC Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e00308","DOI":"10.14309\/ctg.0000000000000308","article-title":"Human intestinal barrier: Effects of stressors, diet, prebiotics, and probiotics","volume":"12","author":"Camilleri","year":"2021","journal-title":"Clin. Trans. Gastroenterol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.coph.2019.07.010","article-title":"Improving therapy of severe infections through drug repurposing of synergistic combinations","volume":"48","author":"Cheng","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11092160","article-title":"The possible role of probiotic supplementation in inflammation: A narrative review","volume":"11","author":"Colletti","year":"2023","journal-title":"Microorganisms"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo7793","article-title":"The past, present, and future of antibiotics","volume":"14","author":"Cook","year":"2022","journal-title":"Sci. Trans. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"110209","DOI":"10.1016\/j.virol.2024.110209","article-title":"A Game of Resistance: War Between Bacteria and Phages and How Phage Cocktails can be the Solution","volume":"599","author":"Costa","year":"2024","journal-title":"Virology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/15592294.2020.1739964","article-title":"Clinical epigenetics and multidrug-resistant bacterial infections: Host remodelling in critical illness","volume":"15","author":"Crimi","year":"2020","journal-title":"Epigenetics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tim.2021.01.003","article-title":"Shaping the future of probiotics and prebiotics","volume":"29","author":"Cunningham","year":"2021","journal-title":"Trends Microbiol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043074","article-title":"Antibiotic-therapy-induced gut dysbiosis affecting gut microbiota\u2013brain axis and cognition: Restoration by intake of probiotics and synbiotics","volume":"24","author":"Dahiya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16020162","article-title":"An overview of biofilm-associated infections and the role of phytochemicals and nanomaterials in their control and prevention","volume":"16","author":"Damyanova","year":"2024","journal-title":"Pharmaceutics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2174\/0115672018296163240910111938","article-title":"Recent developments in oral drug delivery of prokinetic agents: nanoparticles and beyond","author":"Dass","year":"2025","journal-title":"Curr. Drug Delivery"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1360852","article-title":"The effects and mechanisms of natural products on Helicobacter pylori eradication","volume":"14","author":"Deng","year":"2024","journal-title":"Front. Cell. Infection Microbiol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225588","article-title":"Plant-derived inhibitors of AHL-mediated quorum sensing in bacteria: Modes of action","volume":"20","author":"Deryabin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"106617","DOI":"10.1016\/j.micpath.2024.106617","article-title":"Good girl goes bad: understanding how gut commensals cause disease","volume":"190","author":"Dey","year":"2024","journal-title":"Microbial Pathogenesis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11102389","article-title":"Efficacy of different encapsulation techniques on the viability and stability of diverse phage under simulated gastric conditions","volume":"11","author":"Dlamini","year":"2023","journal-title":"Microorganisms"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.572921","article-title":"Gut microbiota resilience: Definition, link to health, and strategies for intervention","volume":"11","author":"Dogra","year":"2020","journal-title":"Front. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.2147\/IDR.S341265","article-title":"Risk of bacteriophage therapeutics to transfer genetic material and contain contaminants beyond endotoxins with clinically relevant mitigation strategies","volume":"14","author":"Doub","year":"2021","journal-title":"Infection Drug Resistance"},{"key":"B36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.copbio.2020.09.006","article-title":"Reprogramming bacteriophage host range: Design principles and strategies for engineering receptor-binding proteins","volume":"68","author":"Dunne","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ph14010034","article-title":"Bacteriophage therapy of bacterial infections: The rediscovered frontier","volume":"14","author":"D\u00fczg\u00fcne\u015f","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106337","article-title":"Enterococcus faecalis in secondary apical periodontitis: Mechanisms of bacterial survival and disease persistence","volume":"183","author":"Elashiry","year":"2023","journal-title":"Microbial Pathogenesis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2217\/fmb-2023-0123","article-title":"Polyphenols and their nanoformulations as potential antibiofilm agents against multidrug-resistant pathogens","volume":"19","author":"Elkhalifa","year":"2024","journal-title":"Future Microbiol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15102416","article-title":"The role of bacteriophages in the gut microbiota: implications for human health","volume":"15","author":"Emencheta","year":"2023","journal-title":"Pharmaceutics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2666-5247(24)00002-8","article-title":"Safety and efficacy of phage application in bacterial decolonisation: a systematic review","volume":"5","author":"Fang","year":"2024","journal-title":"Lancet Microbe"},{"key":"B42","doi-asserted-by":"publisher","first-page":"11278","DOI":"10.7150\/thno.47289","article-title":"Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs","volume":"10","author":"Feng","year":"2020","journal-title":"Theranostics"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/v13122414","article-title":"Past and future of phage therapy and phage-derived proteins in patients with bone and joint infection","volume":"13","author":"Ferry","year":"2021","journal-title":"Viruses"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1038\/s41467-022-31837-9","article-title":"Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection","volume":"13","author":"Ferry","year":"2022","journal-title":"Nat. Commun."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12040765","article-title":"The influence of Helicobacter pylori on human gastric and gut microbiota","volume":"12","author":"Fiorani","year":"2023","journal-title":"Antibiotics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051883","article-title":"Bacteriophage-insensitive mutants of antimicrobial-resistant Salmonella enterica are altered in their tetracycline resistance and virulence in Caco-2 intestinal cells","volume":"21","author":"Fong","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010243","article-title":"Imaging inflammation and infection in the gastrointestinal tract","volume":"21","author":"Frickenstein","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/fermentation8030117","article-title":"Novel developments on stimuli-responsive probiotic encapsulates: From smart hydrogels to nanostructured platforms","volume":"8","author":"Garcia-Brand","year":"2022","journal-title":"Fermentation"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9070414","article-title":"Bacteriophages and the one health approach to combat multidrug resistance: Is this the way","volume":"9","author":"Garvey","year":"2020","journal-title":"Antibiotics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41587-023-01759-y","article-title":"Engineered phage with antibacterial CRISPR\u2013Cas selectively reduce E. coli burden in mice","volume":"42","author":"Gencay","year":"2024","journal-title":"coli burden mice. Nat. Biotechnol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9122485","article-title":"Plant bioactive compounds as an intrinsic and sustainable tool to enhance the microbial safety of crops","volume":"9","author":"George","year":"2021","journal-title":"Microorganisms"},{"key":"B52","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.tim.2018.12.010","article-title":"Alternatives to conventional antibiotics in the era of antimicrobial resistance","volume":"27","author":"Ghosh","year":"2019","journal-title":"Trends Microbiol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8060862","article-title":"Thymol and carvacrol downregulate the expression of Salmonella Typhimurium virulence genes during an in vitro infection on Caco-2 cells","volume":"8","author":"Giovagnoni","year":"2020","journal-title":"Microorganisms"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9110827","article-title":"Phage therapy: towards a successful clinical trial","volume":"9","author":"G\u00f3rski","year":"2020","journal-title":"Antibiotics"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.929346","article-title":"How do intestinal probiotics restore the intestinal barrier","volume":"13","author":"Gou","year":"2022","journal-title":"Front. Microbiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1021\/acsinfecdis.0c00098","article-title":"Multitarget approaches against multiresistant superbugs","volume":"6","author":"Gray","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122137","article-title":"Drug delivery strategies for curcumin and other natural Nrf2 modulators of oxidative stress-related diseases","volume":"13","author":"Grilc","year":"2021","journal-title":"Pharmaceutics"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12050880","article-title":"Antibiotic resistance in selected emerging bacterial foodborne pathogens\u2014An issue of concern","volume":"12","author":"Grudlewska-Buda","year":"2023","journal-title":"Antibiotics"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082453","article-title":"The development of high-quality multispecies probiotic formulations: from bench to market","volume":"12","author":"Grumet","year":"2020","journal-title":"Nutrients"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104798","article-title":"Potential role of probiotics in reducing Clostridioides difficile virulence: Interference with quorum sensing systems","volume":"153","author":"Gunaratnam","year":"2021","journal-title":"Microbial Pathogenesis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40104-019-0402-1","article-title":"Clostridium species as probiotics: potentials and challenges","volume":"11","author":"Guo","year":"2020","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1177\/17562848211018654","article-title":"Economic burden and cost-effectiveness of therapies for Clostridiodes difficile infection: a narrative review","volume":"14","author":"Gupta","year":"2021","journal-title":"Ther. Adv. Gastroenterol."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121993","article-title":"Rise of the guardians: gut microbial maneuvers in bacterial infections","volume":"330","author":"Gupta","year":"2023","journal-title":"Life Sci."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8091420","article-title":"Phage therapy in gastrointestinal diseases","volume":"8","author":"Gutierrez","year":"2020","journal-title":"Microorganisms"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040689","article-title":"Characterization of shigetec, a novel live attenuated combined vaccine against shigellae and etec","volume":"8","author":"Harutyunyan","year":"2020","journal-title":"Vaccines"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2024.39.e44","article-title":"Antibiotic resistance of Helicobacter pylori: Mechanisms and clinical implications","volume":"39","author":"Hasanuzzaman","year":"2024","journal-title":"J. Korean Med. Sci."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11070915","article-title":"Evolutionary dynamics between phages and bacteria as a possible approach for designing effective phage therapies against antibiotic-resistant bacteria","volume":"11","author":"Hasan","year":"2022","journal-title":"Antibiotics"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/ph14030199","article-title":"The age of phage: friend or foe in the new dawn of therapeutic and biocontrol applications","volume":"14","author":"Hassan","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B69","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-med-080219-122208","article-title":"Phage therapy for antibiotic-resistant bacterial infections","volume":"73","author":"Hatfull","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112230","article-title":"Best practice in research\\u2014overcoming common challenges in phytopharmacological research","volume":"246","author":"Heinrich","year":"2020","journal-title":"J. Ethnopharmacology"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuab012","article-title":"Clostridioides difficile phage biology and application","volume":"45","author":"Heuler","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9102049","article-title":"The case against antibiotics and\u00a0for anti-virulence therapeutics","volume":"9","author":"Hotinger","year":"2021","journal-title":"Microorganisms"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodhyd.2022.108165","article-title":"Bioaccessibility and bioavailability of phytochemicals: Influencing factors, improvements, and evaluations","volume":"135","author":"Hu","year":"2023","journal-title":"Food Hydrocolloids"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01694","article-title":"The efficacy of berberine-containing quadruple therapy on Helicobacter pylori eradication in China: A systematic review and meta-analysis of randomized clinical trials","volume":"10","author":"Hu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11030322","article-title":"Antimicrobial potential of curcumin: Therapeutic potential and challenges to clinical applications","volume":"11","author":"Hussain","year":"2022","journal-title":"Antibiotics"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00144","article-title":"The need for personalized approaches to microbiome modulation","volume":"8","author":"Jain","year":"2020","journal-title":"Front. Public Health"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11102393","article-title":"Probiotics and their bioproducts: A promising approach for targeting methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus","volume":"11","author":"Jain","year":"2023","journal-title":"Microorganisms"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12575-021-00147-8","article-title":"Evaluation of the function of probiotics, emphasizing the role of their binding to the intestinal epithelium in the stability and their effects on the immune system","volume":"23","author":"Javanshir","year":"2021","journal-title":"Biol. Procedures Online"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9122580","article-title":"Impact of phage therapy on multidrug-resistant Escherichia coli intestinal carriage in a murine model","volume":"9","author":"Javaudin","year":"2021","journal-title":"Microorganisms"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioteChadv.2021.107758","article-title":"Manufacturing of bacteriophages for therapeutic applications","volume":"49","author":"Jo\u00e3o","year":"2021","journal-title":"Biotechnol. Adv."},{"key":"B81","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1080\/10408398.2019.1672033","article-title":"The antibacterial properties of phenolic isomers, carvacrol and thymol","volume":"60","author":"Kachur","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11071265","article-title":"The impact of quercetin and its methylated derivatives 3-O-methylquercetin and rhamnazin in lipopolysaccharide-induced inflammation in porcine intestinal cells","volume":"11","author":"Karancsi","year":"2022","journal-title":"Antioxidants"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-021-01860-w","article-title":"Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections","volume":"21","author":"Keikha","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.599906","article-title":"A phage therapy guide for clinicians and basic scientists: background and highlighting applications for developing countries","volume":"11","author":"Khalid","year":"2021","journal-title":"Front. Microbiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1016\/j.vaccine.2021.04.018","article-title":"Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access","volume":"39","author":"Khalil","year":"2021","journal-title":"Vaccine"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10091044","article-title":"Phytochemicals: A promising weapon in the arsenal against antibiotic-resistant bacteria","volume":"10","author":"Khameneh","year":"2021","journal-title":"Antibiotics"},{"key":"B87","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tifs.2019.11.019","article-title":"Interactions between probiotics and pathogenic microorganisms in hosts and foods: A review","volume":"95","author":"Khaneghah","year":"2020","journal-title":"Trends Food Sci. Technol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/13880209.2024.2389105","article-title":"Synergistic effect of phenylpropanoids and flavonoids with antibiotics against Gram-positive and Gram-negative bacterial strains","volume":"62","author":"Kincses","year":"2024","journal-title":"Pharm. Biol."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9040293","article-title":"Impact of bacteriophage-supplemented drinking water on the E. coli population in the chicken gut","volume":"9","author":"Kittler","year":"2020","journal-title":"Pathogens"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1038\/s41467-023-39370-z","article-title":"Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa","volume":"14","author":"K\u00f6hler","year":"2023","journal-title":"Nat. Commun."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/foods12020427","article-title":"Investigating the regulatory process, safety, efficacy, and product transparency for nutraceuticals in the USA, Europe, and Australia","volume":"12","author":"Komala","year":"2023","journal-title":"Foods"},{"key":"B92","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00284-022-02874-4","article-title":"Emerging non-traditional approaches to combat antibiotic resistance","volume":"79","author":"Konwar","year":"2022","journal-title":"Curr. Microbiol."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/v12121470","article-title":"In vitro evaluation of a phage cocktail controlling infections with Escherichia coli","volume":"12","author":"Korf","year":"2020","journal-title":"Viruses"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127052","article-title":"Efficacy and safety of phage therapy against Salmonella enterica serovars Typhimurium and Enteritidis estimated using a battery of in vitro tests and the Galleria mellonella animal model","volume":"261","author":"Kosznik-Kwa\u015bnicka","year":"2022","journal-title":"Microbiological Res."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11010110","article-title":"Protective effects of grape seed oligomeric proanthocyanidins in IPEC-J2\u2013Escherichia coli\/Salmonella Typhimurium co-culture","volume":"11","author":"Kov\u00e1cs","year":"2022","journal-title":"Antibiotics"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/ani14131952","article-title":"Effects of luteolin in an in vitro model of porcine intestinal infections","volume":"14","author":"Kov\u00e1cs","year":"2024","journal-title":"Animals"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.609459","article-title":"Futuristic non-antibiotic therapies to combat antibiotic resistance: A review","volume":"12","author":"Kumar","year":"2021","journal-title":"Front. Microbiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/jam.14513","article-title":"Therapeutic bacteriophages as a rescue treatment for drug-resistant infections: An in vivo studies overview","volume":"128","author":"Kwiatek","year":"2020","journal-title":"J. Appl. Microbiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/Spectrum.00517-21","article-title":"Prophylactic administration of a bacteriophage cocktail is safe and effective in reducing Salmonella enterica serovar Typhimurium burden in vivo","volume":"9","author":"Lamy-Besnier","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"B100","doi-asserted-by":"publisher","first-page":"6455","DOI":"10.1080\/10408398.2023.2169858","article-title":"Commercial probiotic products in public health: Current status and potential limitations","volume":"64","author":"Liang","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1042070","article-title":"Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics","volume":"12","author":"Liang","year":"2022","journal-title":"Front. Cell. Infection Microbiol."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13040276","article-title":"Staphylococcus aureus infections and human intestinal microbiota","volume":"13","author":"Liu","year":"2024","journal-title":"Pathogens"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11050570","article-title":"Phage\u2013antibiotic therapy as a promising strategy to combat multidrug-resistant infections and\u00a0to enhance antimicrobial efficiency","volume":"11","author":"Liu","year":"2022","journal-title":"Antibiotics"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/v13071268","article-title":"The safety and toxicity of phage therapy: a review of animal and clinical studies","volume":"13","author":"Liu","year":"2021","journal-title":"Viruses"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/ajt.15687","article-title":"Harnessing the microbiota for therapeutic purposes","volume":"20","author":"Liwinski","year":"2020","journal-title":"Am. J. Transplant."},{"key":"B106","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40259-021-00480-z","article-title":"Engineered bacteriophage therapeutics: rationale, challenges and future","volume":"35","author":"\u0141obocka","year":"2021","journal-title":"BioDrugs"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","article-title":"Phage therapy in the resistance era: Where do we stand and where are we going","volume":"42","author":"Luong","year":"2020","journal-title":"Clin. Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12929-022-00806-1","article-title":"Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far","volume":"29","author":"\u0141usiak-Szelachowska","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411688","article-title":"Antibacterial MccM as the major microcin in against pathogenic enterobacteria Escherichia coli Nissle 1917 against pathogenic enterobacteria","volume":"24","author":"Ma","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/cplu.201900174","article-title":"Recent strategies in\u00a0resveratrol delivery systems","volume":"84","author":"MaChado","year":"2019","journal-title":"ChemPlusChem"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab027","article-title":"Antimicrobial stewardship of antiseptics that are pertinent to wounds: The need for a united approach","volume":"3","author":"Maillard","year":"2021","journal-title":"JAC-Antimicrobial Resistance"},{"key":"B112","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.2147\/IDR.S269845","article-title":"Antimicrobial stewardship: fighting antimicrobial resistance and protecting global public health","volume":"13","author":"Majumder","year":"2020","journal-title":"Infection Drug Resistance"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.jpha.2023.04.010","article-title":"Interactions of naturally occurring compounds\u00a0with antimicrobials","volume":"13","author":"Malczak","year":"2023","journal-title":"J. Pharm. Anal"},{"key":"B114","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000496426","article-title":"Beneficial effects of probiotic consumption on the immune system","volume":"74","author":"Maldonado","year":"2019","journal-title":"Ann. Nutr. Metab."},{"key":"B115","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.copbio.2020.09.005","article-title":"Approaches for manufacture, formulation, targeted delivery, and controlled release of phage-based therapeutics","volume":"68","author":"Malik","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7010","article-title":"Integrating natural compounds and nanoparticle-based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy","volume":"13","author":"Manzari-Tavakoli","year":"2024","journal-title":"Cancer Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12917-023-03724-y","article-title":"Oral phage therapy with microencapsulated phage A221 against Escherichia coli infections in weaned piglets","volume":"19","author":"Mao","year":"2023","journal-title":"BMC Veterinary Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e00062","DOI":"10.1128\/cmr.00062-22","article-title":"Reassessment of historical clinical trials supports the effectiveness of phage therapy","volume":"35","author":"Marongiu","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010184","article-title":"Probiotics mechanism of action on immune cells and beneficial effects on human health","volume":"12","author":"Mazziotta","year":"2023","journal-title":"Cells"},{"key":"B120","doi-asserted-by":"publisher","first-page":"217","DOI":"10.22159\/ijpps.2016v8i10.14062","article-title":"Evaluation of\u00a0phytochemicals and synergistic interaction between plant extracts and antibiotics for efflux pump inhibitory activity against Salmonella enterica serovar typhimurium strains","volume":"8","author":"Mehta","year":"2016","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2185034","article-title":"Emerging issues in probiotic safety: 2023 perspectives","volume":"15","author":"Merenstein","year":"2023","journal-title":"Gut Microbes"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01938","article-title":"Evolutionary approaches to combat antibiotic resistance: opportunities and challenges for precision medicine","volume":"11","author":"Merker","year":"2020","journal-title":"Front. Immunol."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11090977","article-title":"Bacteraemia caused by probiotic strains of Lacticaseibacillus rhamnosus \u2014 case studies highlighting the need for careful thought before using microbes for health benefits","volume":"11","author":"Mikucka","year":"2022","journal-title":"Pathogens"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105552","article-title":"Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases","volume":"166","author":"Mohammadi","year":"2022","journal-title":"Microbial Pathogenesis"},{"key":"B125","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12223-023-01046-y","article-title":"Phage therapy of antibiotic-resistant strains of Klebsiella pneumoniae, opportunities and challenges from the past to the future","volume":"68","author":"Mohammadi","year":"2023","journal-title":"Folia Microbiologica"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2127633","article-title":"Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic","volume":"14","author":"Mortzfeld","year":"2022","journal-title":"Gut Microbes"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.825338","article-title":"Recent advances in understanding the structure and function of the human microbiome","volume":"13","author":"Mousa","year":"2022","journal-title":"Front. Microbiol."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813783","article-title":"Probiotics modulate host immune response and interact with the gut microbiota: shaping their composition and mediating antibiotic resistance","volume":"24","author":"Mousa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-021-01155-1","article-title":"Assessment of the microbiome during bacteriophage therapy in combination with systemic antibiotics to treat a case of staphylococcal device infection","volume":"9","author":"Mu","year":"2021","journal-title":"Microbiome"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040356","article-title":"\u03b2-glucan metabolic and immunomodulatory properties and potential for clinical application","volume":"6","author":"Murphy","year":"2020","journal-title":"J.\u00a0Fungi"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11020200","article-title":"Progress in alternative strategies to combat antimicrobial resistance: Focus on antibiotics","volume":"11","author":"Murugaiyan","year":"2022","journal-title":"Antibiotics"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2022.101208","article-title":"Phage banks as potential tools to rapidly and cost-effectively manage antimicrobial resistance in the developing world","volume":"53","author":"Nagel","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3390\/v14122772","article-title":"Diversity, dynamics, and therapeutic application of Clostridioides difficile bacteriophages","volume":"14","author":"Nale","year":"2022","journal-title":"Viruses"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.clinthera.2020.07.011","article-title":"The role of probiotics, prebiotics, and synbiotics in combating multidrug-resistant organisms","volume":"42","author":"Newman","year":"2020","journal-title":"Clin. Ther."},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12091920","article-title":"An overview of the recent advances in antimicrobial resistance","volume":"12","author":"Oliveira","year":"2024","journal-title":"Microorganisms"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116038","article-title":"Evaluation of in vitro synergistic effects of tetracycline with alkaloid-related compounds against diarrhoeic bacteria","volume":"25","author":"Osei-Owusu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2021.110658","article-title":"Morphological and metabolomics impact of sublethal doses of natural compounds and its nanoemulsions in Bacillus cereus","volume":"149","author":"Pagnossa","year":"2021","journal-title":"Food Res. Int."},{"key":"B138","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/1040841X.2022.2163577","article-title":"Probiotics: Insights and new opportunities for Clostridioides difficile intervention","volume":"49","author":"Pal","year":"2023","journal-title":"Crit. Rev. Microbiol."},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1029098","article-title":"Recent advances to combat ESKAPE pathogens with\u00a0special reference to essential oils","volume":"13","author":"Panda","year":"2022","journal-title":"Front. Microbiol."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3390\/ph17030329","article-title":"Lipid-based nanoparticles in delivering bioactive compounds for improving therapeutic efficacy","volume":"17","author":"Patel","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B141","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/13543784.2024.2326028","article-title":"Antibacterial agents active against Gram negative bacilli in phase I, II, or III clinical trials","volume":"33","author":"Paterson","year":"2024","journal-title":"Expert Opin. Investigational Drugs"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.2174\/1389201025666220913105632","article-title":"Potential of flavonoids as promising phytotherapeutic agents to combat multidrug-resistant infections","volume":"25","author":"Pathak","year":"2024","journal-title":"Curr. Pharm. Biotechnol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MOP.0000000000000752","article-title":"Arguments against\u00a0routine administration of probiotics for NEC prevention","volume":"31","author":"Pell","year":"2019","journal-title":"Curr. Opin. Pediatr."},{"key":"B144","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3920\/BM2018.0133","article-title":"Mechanisms and immunomodulatory properties of pre-and probiotics","volume":"10","author":"Peters","year":"2019","journal-title":"Beneficial Microbes"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e3002119","DOI":"10.1371\/journal.pbio.3002119","article-title":"Translating phage therapy into the clinic: Recent accomplishments but continuing challenges","volume":"21","author":"Petrovic Fabijan","year":"2023","journal-title":"PloS Biol."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/nu15061504","article-title":"Ellagitannins from Castanea sativa Mill. Leaf Extracts Impair Helicobacter pylori Viability and Infection-Induced Inflammation in Human Gastric Epithelial Cells","volume":"15","author":"Piazza","year":"2023","journal-title":"Nutrients"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41564-022-01128-4","article-title":"Phage\u2013host coevolution in natural populations","volume":"7","author":"Piel","year":"2022","journal-title":"Nat. Microbiol."},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00952","article-title":"Innovative strategies toward the disassembly of the EPS matrix in bacterial biofilms","volume":"11","author":"Pinto","year":"2020","journal-title":"Front. Microbiol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1093\/advances\/nmz049","article-title":"Mechanisms of action of probiotics","volume":"10","author":"Plaza-Diaz","year":"2019","journal-title":"Adv. Nutr."},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12020333","article-title":"Plant-derived products with therapeutic potential against gastrointestinal bacteria","volume":"12","author":"Qassadi","year":"2023","journal-title":"Pathogens"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2356279","article-title":"The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes","volume":"16","author":"Rahman","year":"2024","journal-title":"Gut Microbes"},{"key":"B152","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/immuno2020022","article-title":"Effect of wild blueberry metabolites on biomarkers of gastrointestinal and immune health in vitro","volume":"2","author":"Rathinasabapathy","year":"2022","journal-title":"Immuno"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136729","article-title":"Probiotics, prebiotics and epithelial tight junctions: A promising approach to modulate intestinal barrier function","volume":"22","author":"Rose","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/biomimetics8010074","article-title":"Microfluidic fabrication of natural polymer-based scaffolds for tissue engineering applications: A review","volume":"8","author":"Rosellini","year":"2023","journal-title":"Biomimetics"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11090986","article-title":"Effect of probiotics on host-microbiota in bacterial infections","volume":"11","author":"Rueda-Robles","year":"2022","journal-title":"Pathogens"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2019.108806","article-title":"Exploitation of plant extracts and phytochemicals against resistant Salmonella spp. in biofilms","volume":"128","author":"Sakarikou","year":"2020","journal-title":"Food Res. Int."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11131946","article-title":"Antimicrobial resistance: A growing serious threat for global public health","volume":"11","author":"Salam","year":"2023","journal-title":"Healthcare"},{"key":"B158","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.00219-21","article-title":"Antiviral resistance and phage counter-adaptation to antibiotic-resistant extraintestinal pathogenic Escherichia coli","volume":"12","author":"Salazar","year":"2021","journal-title":"mBio"},{"key":"B159","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"The role of molecular imaging in personalized medicine","volume":"13","author":"Salih","year":"2023","journal-title":"J. Personalized Med."},{"key":"B160","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"B161","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nature20557","article-title":"Microcins mediate competition among Enterobacteriaceae in the inflamed gut","volume":"540","author":"Sassone-Corsi","year":"2016","journal-title":"Nature"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105594","article-title":"A new approach against Helicobacter pylori using plants and its constituents: A review study","volume":"168","author":"Sathianarayanan","year":"2022","journal-title":"Microbial Pathogenesis"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12081044","article-title":"Patterns, cost, and immunological response of MDR vs non-MDR bacteremia: A prospective cohort study","volume":"12","author":"SChinas","year":"2023","journal-title":"Pathog."},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2018.01973","article-title":"St. John\\u2019s Wort (Hypericum perforatum) products\\u2014How variable is the primary material","volume":"9","author":"Scotti","year":"2019","journal-title":"Front. Plant Sci."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1080\/19490976.2020.1770666@kgmi20.2020.12.issue-SI1","article-title":"Vaccines against gastroenteritis, current progress and challenges","volume":"11","author":"Seo","year":"2020","journal-title":"Gut Microbes"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104080","article-title":"Probiotics as an alternative antimicrobial therapy: Current reality and future directions","volume":"73","author":"Silva","year":"2020","journal-title":"J. Funct. Foods"},{"key":"B167","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2147\/IDR.S328646","article-title":"How good are bacteriophages as an alternative therapy to mitigate biofilms of nosocomial infections","volume":"15","author":"Singh","year":"2022","journal-title":"Infection Drug Resistance"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100749","article-title":"Plant natural flavonoids against multidrug-resistant pathogens","volume":"8","author":"Song","year":"2021","journal-title":"Advanced Sci."},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02192","article-title":"Probiotics in medicine: A long debate","volume":"11","author":"Stavropoulou","year":"2020","journal-title":"Front. Immunol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"e02071","DOI":"10.1128\/aac.02071-21","article-title":"Considerations for the use of phage therapy in clinical practice","volume":"66","author":"Suh","year":"2022","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jme-2023-109423","article-title":"Ethical argument for establishing good manufacturing practice for phage therapy in the UK","author":"Suleman","year":"2024","journal-title":"J. Med. Ethics"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3390\/ph13100299","article-title":"The principles, mechanisms, and benefits of unconventional agents in the treatment of biofilm infection","volume":"13","author":"Talapko","year":"2020","journal-title":"Pharmaceuticals"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.552020","article-title":"Chlorogenic acid promotes autophagy and alleviates Salmonella Typhimurium infection through the lncRNA GAS5\/miR-23a\/PTEN axis and the p38 MAPK pathway","volume":"8","author":"Tan","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"e12944","DOI":"10.1111\/jfbc.12944","article-title":"Health-promoting activities of probiotics","volume":"43","author":"Tang","year":"2019","journal-title":"J. Food Biochem."},{"key":"B175","first-page":"43","article-title":"Pro-, pre-, and post-biotics related to gut microbiota and immune system","volume":"30","author":"Tasaka","year":"2023","journal-title":"Japanese J. Food Chem. Saf."},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9060314","article-title":"Activity of specialized biomolecules against gram-positive and gram-negative bacteria","volume":"9","author":"Tavares","year":"2020","journal-title":"Antibiotics"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041317","article-title":"Natural compounds: Co-delivery strategies with chemotherapeutic agents or nucleic acids using lipid-based nanocarriers","volume":"15","author":"Teixeira","year":"2023","journal-title":"Pharmaceutics"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3390\/v13102049","article-title":"Phage therapy related microbial succession associated with successful clinical outcome for a recurrent urinary tract infection","volume":"13","author":"Terwilliger","year":"2021","journal-title":"Viruses"},{"key":"B179","doi-asserted-by":"publisher","first-page":"e00422","DOI":"10.1128\/spectrum.00422-22","article-title":"Prophylactic delivery of a bacteriophage cocktail in feed significantly reduces Salmonella colonization in pigs","volume":"10","author":"Thanki","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B180","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3316\/agispt.20240102101366","article-title":"The promising viral threat to bacterial resistance: The uncertain patentability of phage therapeutics and the necessity of alternative incentives","volume":"68","author":"Todd","year":"2019","journal-title":"Duke Law J."},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10020175","article-title":"Bacteriophage-derived depolymerases against bacterial biofilm","volume":"10","author":"Topka-Bielecka","year":"2021","journal-title":"Antibiotics"},{"key":"B182","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/1040841X.2020.1720080","article-title":"Recent advances in tackling microbial multidrug resistance with essential oils: Combinatorial and nano-based strategies","volume":"46","author":"Trifan","year":"2020","journal-title":"Crit. Rev. Microbiol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jpedsurg.2018.08.062","article-title":"Probiotics and the prevention of necrotizing enterocolitis","volume":"54","author":"Underwood","year":"2019","journal-title":"J. Pediatr. Surg."},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10020145","article-title":"Pseudomonas aeruginosa resistance to bacteriophages and its prevention by strategic therapeutic cocktail formulation","volume":"10","author":"Vaitekenas","year":"2021","journal-title":"Antibiotics"},{"key":"B185","doi-asserted-by":"crossref","DOI":"10.17533\/udea.rfnsp.v38n1e337759","article-title":"Resistencia antimicrobiana en el siglo XXI: \u00bfHacia una era postantibi\u00f3tica","volume-title":"Revista Facultad Nacional de Salud Publica","author":"Vanegas-M\u00fanera","year":"2020"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1831339","article-title":"Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria","volume":"12","author":"Van Zyl","year":"2020","journal-title":"Gut\u00a0Microbes"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9102041","article-title":"Towards advances in medicinal plant antimicrobial activity: A review study on challenges and future perspectives","volume":"9","author":"Vaou","year":"2021","journal-title":"Microorganisms"},{"key":"B188","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coviro.2022.02.005","article-title":"European regulatory aspects of phage therapy:\u00a0Magistral phage preparations","volume":"52","author":"Verbeken","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041331","article-title":"Effects of anthocyanin on intestinal health: A systematic review","volume":"13","author":"Verediano","year":"2021","journal-title":"Nutrients"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3390\/foods10071564","article-title":"Natural bioactive compounds from food waste: Toxicity and safety concerns","volume":"10","author":"Vilas-Boas","year":"2021","journal-title":"Foods"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071382","article-title":"Vaccines for protecting infants from bacterial causes of diarrheal disease","volume":"9","author":"Walker","year":"2021","journal-title":"Microorganisms"},{"key":"B192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000534717","article-title":"The potential of bacteriophage therapy as an alternative treatment approach for antibiotic-resistant infections","volume":"33","author":"Walter","year":"2024","journal-title":"Med. Principles Pract."},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlac066","article-title":"Antibiotic stewardship in the era of precision medicine","volume":"4","author":"Watkins","year":"2022","journal-title":"JAC-Antimicrobial Resistance"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015493","article-title":"The combination of antibiotic and non-antibiotic compounds improves antibiotic efficacy against multidrug-resistant bacteria","volume":"24","author":"Xiao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1250848","article-title":"Regulations of phage therapy across the world","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Microbiol."},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8638103","article-title":"Effects of natural products on bacterial communication and network-quorum sensing","volume":"2020","author":"Yang","year":"2020","journal-title":"BioMed. Res. Int."},{"key":"B198","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/1541-4337.12535","article-title":"Progress in microencapsulation of probiotics: A review","volume":"19","author":"Yao","year":"2020","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"B199","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00203-023-03826-z","article-title":"Biofilm-mediated infections by multidrug-resistant microbes: A comprehensive exploration and forward perspectives","volume":"206","author":"Zafer","year":"2024","journal-title":"Arch. Microbiol."},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19095701","article-title":"Microbiological testing of probiotic preparations","volume":"19","author":"Zawistowska-Rojek","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1039\/D0NP00098E","article-title":"Cytochrome P450 enzymes in fungal natural product biosynthesis","volume":"38","author":"Zhang","year":"2021","journal-title":"Natural Product Rep."},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25204626","article-title":"Preventative and therapeutic potential of flavonoids in peptic ulcers","volume":"25","author":"Zhang","year":"2020","journal-title":"Molecules"},{"key":"B203","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.2147\/IDR.S426805","article-title":"Potentiation and mechanism of berberine as an antibiotic adjuvant against multidrug-resistant bacteria","volume":"16","author":"Zhou","year":"2023","journal-title":"Infection Drug Resistance"}],"container-title":["Frontiers in Antibiotics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frabi.2025.1554061\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T05:26:57Z","timestamp":1746509217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frabi.2025.1554061\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":203,"alternative-id":["10.3389\/frabi.2025.1554061"],"URL":"https:\/\/doi.org\/10.3389\/frabi.2025.1554061","relation":{},"ISSN":["2813-2467"],"issn-type":[{"value":"2813-2467","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"article-number":"1554061"}}